Division of Biomedical Research & Development Iwate Medical University Institute for Biomedical Sciences

News

  • 2026.09.26

    Hiraki  gave a presentation on the OTS-Assay at the 85th Annual Meeting of the Japanese Cancer Association (Kyoto).
  • 2026.09.25

    Nishizuka gave a talk on the OTS-Assay at the 85th Annual Meeting of the Japanese Cancer Association (Kyoto).
  • 2026.09.23

    Nishizuka gave a talk on the OTS-Assay at the Special Symposium of the 46th Annual Meeting of the Japanese Society of Molecular Tumor Markers (Kyoto).
  • 2026.09.17

    Nishizuka gave a talk on the OTS-Assay at the 8th Multi-Site Joint Medical Conference (Online).
  • 2026.09.16

    Takeshi Iwaya, MD, PhD, from the Department of Clinical Oncology, Iwate Medical University,  gave a talk at ISDE2026, the 22nd World Congress for Esophageal Diseases (Kyoto).

Alteration of
an Opt-Out Choice

Last Updated : 2026.10.09

Precautions

Our patient opt-out policy permits participants to choose whether they want to use their personal information and specimens provided for our medical research. According to the policy of the Japanese Government, patients or people acting as their proxies have the right to alter the opt-out choice they made when giving informed consent for the medical research. We are currently announcing the above protocols for the opt-out opportunities. Please note, however, that we may not be able to identify individuals once their personal information and specimens provided for our medical research have been anonymously processed.